Falicov Alexis, Fisher Charles G, Sparkes Joe, Boyd Michael C, Wing Peter C, Dvorak Marcel F
Vancouver Spine Program, Vancouver General Hospital, Vancouver, British Columbia, Canada.
Spine (Phila Pa 1976). 2006 Nov 15;31(24):2849-56. doi: 10.1097/01.brs.0000245838.37817.40.
Prospective clinical study.
To assess Health-Related Quality of Life outcomes in patients undergoing surgery for spinal metastases.
Increasing life expectancy of patients with spinal metastases has resulted in greater interest in overall quality of life, including pain and neurologic impairment. To assess the overall risks and benefits of surgical intervention, the overall impact of each on the overall health status must be assessed.
All patients who presented to a single institution with bony spinal metastases requiring surgical intervention were eligible.
previous surgery for spinal metastases, primary tumors of the spine, and inability to fill out the questionnaires. Patients completed an EORTC QLQ-C30, the HUI-3, the EQ-5D, visual analog pain, and an ECOG functional assessment. at five points: before surgery and at 6 weeks, 3 months, 6 months, and 1 year post surgery.
Of 96 patients who presented to the hospital, 85 were enrolled in the study. Average age was 58.6 years (range, 20.3-80.7 years) with 47 male patients; 50% survival as 39.1 weeks. Maximal and average VAS pain levels showed a statistically significant (P < 0.00001) improvement from preoperative to all postoperative time points. Only the QLQ-C30 global health status showed a statistically significant improvement from preoperative to the 6-week (P = 0.017), 3-month (P = 0.039), and 6-month (P = 0.013) time points. There was a statistically significant correlation between baseline global health status and survival time (P = 0.041). Overall distribution of HUI-3 utility calculated Quality of Life Adjusted Years (QALY) during the 1-year postoperative period showed a bimodal distribution with peaks at 0.1 and 0.7 years.
Surgery for patients with spinal metastases offers decreased pain and improved quality of life with low rates of surgical complications.
前瞻性临床研究。
评估接受脊柱转移瘤手术患者的健康相关生活质量结局。
脊柱转移瘤患者预期寿命的延长使得人们对包括疼痛和神经功能障碍在内的总体生活质量愈发关注。为评估手术干预的总体风险和益处,必须评估其对整体健康状况的综合影响。
所有因脊柱骨转移至单一机构就诊且需要手术干预的患者均符合条件。
既往有脊柱转移瘤手术史、原发性脊柱肿瘤以及无法填写问卷者。患者在五个时间点完成了欧洲癌症研究与治疗组织核心生活质量问卷(EORTC QLQ-C30)、健康效用指数-3(HUI-3)、欧洲五维度健康量表(EQ-5D)、视觉模拟疼痛评分以及美国东部肿瘤协作组(ECOG)功能评估,这五个时间点分别为手术前、术后6周、3个月、6个月和1年。
96例到院患者中,85例纳入研究。平均年龄58.6岁(范围20.3 - 80.7岁),男性患者47例;50%的患者生存期为39.1周。从术前到所有术后时间点,最大和平均视觉模拟疼痛评分水平均有统计学显著改善(P < 0.00001)。仅QLQ-C30总体健康状况从术前到术后6周(P = 0.017)、3个月(P = 0.039)和6个月(P = 0.013)时间点有统计学显著改善。基线总体健康状况与生存时间之间存在统计学显著相关性(P = 0.041)。术后1年期间计算得出的HUI-3效用值的总体生活质量调整生命年(QALY)分布呈双峰分布,峰值出现在0.1年和0.7年。
脊柱转移瘤患者手术可减轻疼痛,提高生活质量,且手术并发症发生率低。